WHO ICTRP trial
A Study to Assess Adverse Events and Change in Disease Activity of Multiple…
CTIS2025-521606-18-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2025-521606-18-00 |
|---|---|
| Public title | A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations with Intravenous Mirvetuximab Soravtansine in Adult Participants with Ovarian Cancer |
| Scientific title | A Phase 2, Open-Label, Randomized, Master Protocol Dose Optimization Study to Evaluate Safety and Efficacy of Multiple Treatment Combinations with Mirvetuximab Soravtansine in Subjects with Ovarian Cancer (FLORENZA) - M25-709 |
| Primary sponsor | AbbVie Deutschland GmbH & Co. KG |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Australia;Korea, Republic of;United States;Belgium;Czechia;Denmark;France;Spain |
| Conditions | Ovarian Cancer MedDRA version: 20.0Level: PTClassification code: 10033128Term: Ovarian cancer Class: 100000004864;Therapeutic area: Diseases [C] - Neoplasms [C04] |
| Interventions | Product Name: CARBOPLATIN, Product Code:SUB06614MIG, Pharmaceutical Form: SOLUTION FOR INJECTION, Other descriptive name: , Strength: , Product Name: BEVACIZUMAB, Product Code:SUB16402MIG, Pharmaceutical Form: CONCENTRATE FOR SOLUTION FOR… |
| Registration date | Sep 18, 2025 |
| Target size | 320 |
| Secondary IDs | NCT07059845 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: